BILL ANALYSIS �
Senate Appropriations Committee Fiscal Summary
Senator Christine Kehoe, Chair
SB 1538 (Simitian) - Mammograms
Amended: March 27, 2012 Policy Vote: Health 9-0
Urgency: No Mandate: No
Hearing Date: April 30, 2012
Consultant: Brendan McCarthy
This bill meets the criteria for referral to the Suspense File.
Bill Summary: SB 1538 would require facilities that perform
mammograms to include a specified notice with the reports that
are sent to certain patients. The notice would tell the patient
that she has dense breasts and may benefit from supplemental
screening.
Fiscal Impact: Increased costs to state health programs due to
requests for additional screening from participants. Assuming
that 10 percent of women who receive the required notice request
additional screening, costs to state health programs would be:
Medi-Cal: about $1.8 million per year (50% General Fund and
50% federal funds)
Every Woman Counts Program: about $1.6 million per year
(General Fund)
CalPERS: about $1.7 million per year (55% General Fund and
45% special funds)
Background: Federal law requires facilities that perform
mammograms to provide a written report of the mammogram
examination to both the patient and the referring health care
provider. Included in the report to the health care provider is
information on the patient's breast density.
Proposed Law: SB 1538 requires facilities that perform
mammograms to include a specified notice in the reports that are
provided to women who are classified as having dense breasts.
(Whether or not a woman is classified as having dense breasts is
based on a classification system developed by the American
College of Radiology.) The notice states:
"Because your mammogram demonstrates that you have dense breast
SB 1538 (Simitian)
Page 1
tissue, which could hide small abnormalities, you might benefit
from supplementary screening tests, depending on your individual
risk factors. A report of your mammography results, which
contains information about your breast density, has been sent to
your physician's office and you should contact your physician if
you have any questions or concerns about this notice"
The bill would take effect on April 1, 2013 and would sunset on
January 1, 2019. The bill further specifies that it does not
impose any liability on a health care facility that does not
comply with its provisions before April 1, 2013.
Related Legislation: SB 173 (Simitian, 2011) was substantially
similar to this bill and included the same notice. That bill was
held in the Assembly Appropriations Committee.
SB 791 (Simitian, 2011) was also substantially similar to this
bill and included the same notice. That bill was vetoed by
Governor Brown.
Staff Comments: Roughly 50 percent of women who receive
mammograms have breasts that would be classified as dense, under
the provisions of the bill. The fiscal estimates above assume
that ten percent of the women who receive the required notice
would request additional screening from their provider. Most
health plans will cover breast ultrasound if referred by a
provider, whereas breast magnetic resonance imaging scans are
not generally covered without prior authorization. This analysis
assumes that only breast ultrasounds are used for supplemental
screening. If either the rate of requests for supplemental
screening or the use of breast magnetic resonance imaging is
higher, costs to public programs would be higher.
According to an analysis of SB 173 by the California Health
Benefits Review Program: there is insufficient evidence that
breast ultrasound improves the sensitivity of screening for
asymptomatic women with dense breasts; breast ultrasounds yield
false positives at twice the rate of mammograms; and there is
insufficient evidence that breast ultrasound screening decreases
mortality or improves health outcomes.
In addition, the analysis found that: breast magnetic resonance
imaging may be useful to identify cancer in women with high risk
factors; false positive rates are twice as high as for
SB 1538 (Simitian)
Page 2
mammograms; and there is insufficient evidence that breast
magnetic resonance imaging screening reduces mortality or
improves outcomes.
Therefore, there is not enough available evidence to determine
whether additional screening requested due to the bill will
result in improved health outcomes or reduced long-term
healthcare costs.